Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 0.9465
-0.0485 (-4.87%)
Oct 22, 2026, 5:35 PM CEST
Cellectis Market Cap
Cellectis has a market cap or net worth of €68.81 million as of October 22, 2026. It is the 26,953rd most valuable company in the world and the 335th biggest in France. Its market cap has decreased by 69.60% in one year.
Market Cap
68.81M
Enterprise Value
-6.76M
Revenue
55.86M
Global Rank
Country Rank
#335 France
PE Ratio
n/a
ChartMarket Cap Chart
Since February 7, 2007, Cellectis's market cap has decreased from 100.59M to 68.81M, a decrease of -31.60%. That is a compound annual growth rate of -1.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 68.81M | -77.32% |
| Dec 31, 2025 | 303.40M | 158.68% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 200.28M |
| Transgene | 185.69M |
| Innate Pharma | 126.31M |
| Sensorion | 94.91M |
| ABIONYX Pharma | 69.60M |
| OSE Immunotherapeutics | 48.69M |
| THX Pharma Société Anonyme | 48.43M |
| Adocia | 47.22M |